AMERICAN JOURNAL OF PERINATOLOGY, vol.31, no.6, pp.463-467, 2014 (SCI-Expanded, Scopus)
Background Some controlled trials have shown significant differences in short-term clinical outcomes between poractant alfa and beractant in infants with respiratory distress syndrome (RDS). There is, however, no study showing the differences in long-term outcomes with these treatments.